Insider Trading June 3, 2026 07:17 PM

Insider Activity and Recent Earnings Provide Mixed Signals for StepStone Group

Co-COO Fernandez sells $9.6 million in shares via 10b5-1 plan amidst stock decline, while recent quarterly results signal strong fee growth.

By Hana Yamamoto STEP

Jose A. Fernandez, Co-Chief Operating Officer of StepStone Group Inc., sold approximately $9.61 million worth of company shares between June 1 and June 3, 2026, utilizing a Rule 10b5-1 trading plan. This activity occurs as the stock has declined significantly over the past week. Separately, the company recently reported strong financial performance for the fourth quarter of fiscal 2026, noting a substantial increase in fee-related earnings and an adjusted net income that surpassed analyst expectations.

Insider Activity and Recent Earnings Provide Mixed Signals for StepStone Group
STEP

Key Points

  • The recent quarter saw strong financial performance for StepStone Group, highlighted by an adjusted net income of $0.57 per share, surpassing estimates.
  • Management fees and lower general/administrative expenses were the primary catalysts driving the positive results in Q4 fiscal 2026.
  • BMO Capital upgraded its price target from $54 to $62 and maintained an Outperform rating based on strong fee growth.

The recent insider trading activity by StepStone Group Inc.'s (NASDAQ:STEP) Co-Chief Operating Officer, Jose A. Fernandez, highlights notable transactions involving the sale of company shares. Between June 1 and June 3, 2026, Mr. Fernandez sold a total of 202,290 shares of the company’s Class A Common Stock, amounting to approximately $9.61 million in value. These dispositions were executed through the use of a Rule 10b5-1 trading plan, indicating a pre-arranged schedule for selling equity.

The sale encompassed various price points, ranging from $42.64 up to $50.59 per share. It is important to note that all shares sold during this period were held indirectly through a trust structure.

Details of the Insider Sales

On June 1, Mr. Fernandez’s trust conducted four distinct transactions involving Class A Common Stock. The initial sales included 28,324 shares at a weighted average price of $47.90, with individual prices observed between $47.25 and $48.24. Further disposals on this date involved 56,176 shares sold at a weighted average price of $48.57 (ranging from $48.25 to $49.18). The day’s trading also accounted for 12,117 shares at a weighted average price of $49.78 (priced between $49.31 and $50.29), followed by the sale of 3,383 shares at a weighted average price of $50.59 (with prices ranging from $50.31 to $50.93).

Activity continued on June 2, when an additional 85,200 shares were sold at a weighted average price of $46.41, with trades occurring between $46.00 and $46.99. Another set of sales included 14,800 shares at a weighted average price of $47.33, spanning prices from $47.00 to $47.76.

The final reported sale on June 3 comprised 2,290 shares sold at the specific price of $42.64.

Market Context and Valuation Metrics

These insider sales occurred amidst notable pressure on STEP shares. Over the preceding week, the stock had declined by 16.6%, trading at $43.61. This current price level is situated near its 52-week low of $40.58. Despite the recent downward trend, one analysis suggests that the stock may currently be undervalued, pointing to a Fair Value estimate of $46.30, which places it on lists identifying highly undervalued securities. The company maintains a market capitalization of $5.54 billion and offers investors a dividend yield of 3.83%.

Current Holdings and Corporate Strength

Following the series of transactions through the trust, Mr. Fernandez’s indirect holdings of Class A Common Stock are now recorded as zero shares. His direct ownership remains at 16,538 shares of Class A Common Stock. The reported direct holding is explained as a correction to previous filings that had mistakenly misreported shares transferred to the Fernandez Family Trust. Furthermore, Mr. Fernandez’s indirect holdings include 3,016,601 shares of Class B Common Stock through a trust and an additional 1,605,500 shares of Class B Common Stock via Santaluz Capital Partners, LLC.

Shifting focus to the company's operational health, StepStone Group Inc. recently released robust financial results for the fourth quarter of fiscal 2026. The firm reported fee-related earnings (FRE) totaling $105 million. This figure represents a 12% increase when compared to the corresponding period in the previous year.

While the company recorded a GAAP net loss of $7.8 million, translating to $0.10 per share, this loss was attributed specifically to fair value adjustments. However, the adjusted net income demonstrated strength, reaching $69 million, or $0.57 per share. This adjusted figure successfully exceeded the consensus estimate provided by analysts, which stood at $0.49 per share. Management fees and reduced general and administrative expenses were cited as key drivers for this positive performance.

In addition to quarterly results, StepStone Group further enhanced its asset structure by completing its third exchange aimed at acquiring additional equity interests in its various real estate, real assets, and private debt entities. This ongoing activity means the company now holds approximately 65% of the outstanding equity within each of these specific entities. The positive financial developments were recognized externally when BMO Capital updated its price target for StepStone Group shares from $54 to $62, while maintaining an Outperform rating. This increased valuation reflects confidence in the company's continuing fee growth and the strength demonstrated by its fourth-quarter results.


Risks

  • The stock has faced recent downward pressure, declining 16.6% over the past week, suggesting market volatility.
  • GAAP net loss of $7.8 million for Q4 fiscal 2026 was recorded due to fair value adjustments, indicating potential accounting fluctuations that could impact perceived stability.

More from Insider Trading

Maplebear Director Ravi Gupta Offloads $7.5 Million Stake Amid Steady Operational Metrics Jun 4, 2026 United Therapeutics Executive Mahon Liquidates $4.54 Million Stake Under Pre-Arranged Plan Jun 4, 2026 Globalstar Executive Disposes of Shares Amidst Valuation Questions and Acquisition Speculation Jun 4, 2026 Saba Capital Management Expands Stake in Highland Opportunities & Income Fund Jun 4, 2026 Oscar Health Executive Victoria Baltrus Liquidates Shares Under Pre-Arranged Plan Jun 4, 2026